| Literature DB >> 31980599 |
Tamer Butto1, Niklas Hammer2, Alexis Cooper3, Somanath Jagannath2, Desiree Lucia Fend-Guella3, Junaid Akhtar1, Konstantin Radyushkin4, Florian Lesage5, Jennifer Winter3,4, Susanne Strand6, Jochen Roeper2, Ulrich Zechner7,8, Susann Schweiger9,10,11,12.
Abstract
Mutations in the actively expressed, maternal allele of the imprinted KCNK9 gene cause Birk-Barel intellectual disability syndrome (BBIDS). Using a BBIDS mouse model, we identify here a partial rescue of the BBIDS-like behavioral and neuronal phenotypes mediated via residual expression from the paternal Kcnk9 (Kcnk9pat) allele. We further demonstrate that the second-generation HDAC inhibitor CI-994 induces enhanced expression from the paternally silenced Kcnk9 allele and leads to a full rescue of the behavioral phenotype suggesting CI-994 as a promising molecule for BBIDS therapy. Thus, these findings suggest a potential approach to improve cognitive dysfunction in a mouse model of an imprinting disorder.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31980599 PMCID: PMC6981138 DOI: 10.1038/s41467-019-13918-4
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919